Sattar, Naveed

Physical capability markers used to define sarcopenia and their association with cardiovascular and respiratory outcomes and all-cause mortality: A prospective study from UK Biobank

Petermann-Rocha, F., Ho, F. K., Welsh, P., Mackay, D., Brown, R., Gill, J. M. R., Sattar, N., Gray, S. R., Pell, J. P., & Celis-Morales, C. A. (2020) · Maturitas

Nutrition and Health in AgingFrailty in Older Adults

Cited by 52

Personality, Socio-Economic Status and Inflammation: Cross-Sectional, Population-Based Study

Millar, K., Lloyd, S. M., McLean, J. S., Batty, G. D., Burns, H., Cavanagh, J., Deans, K. A., Ford, I., McConnachie, A., McGinty, A., et al. (2013) · PLoS ONE

Health disparities and outcomesTryptophan and brain disorders

Cited by 47

The effect of dapagliflozin on glycaemic control and other cardiovascular disease risk factors in type 2 diabetes mellitus: a real-world observational study

on behalf of the Scottish Diabetes Research Network Epidemiology Group, McGurnaghan, S. J., Brierley, L., Caparrotta, T. M., McKeigue, P. M., Blackbourn, L. A. K., Wild, S. H., Leese, G. P., McCrimmon, R. J., McKnight, J. A., et al. (2019) · Diabetologia

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 46

Disease consequences of higher adiposity uncoupled from its adverse metabolic effects using Mendelian randomisation

Martin, S., Tyrrell, J., Thomas, E. L., Bown, M. J., Wood, A. R., Beaumont, R. N., Tsoi, L. C., Stuart, P. E., Elder, J. T., Law, P., et al. (2022) · eLife

Genetic Associations and EpidemiologyAdipokines, Inflammation, and Metabolic Diseases

Cited by 43

Culturally adapting the prevention of diabetes and obesity in South Asians (PODOSA) trial

Wallia, S., Bhopal, R. S., Douglas, A., Bhopal, R., Sharma, A., Hutchison, A., Murray, G., Gill, J., Sattar, N., Lawton, J., et al. (2014) · Health Promotion International

Diabetes Management and EducationCultural Competency in Health Care

Cited by 42

Association of gamma-glutamyltransferase levels with total mortality, liver-related and cardiovascular outcomes: a prospective cohort study in the UK Biobank

Ho, F. K., Ferguson, L. D., Celis-Morales, C. A., Gray, S. R., Forrest, E., Alazawi, W., Gill, J. M., Katikireddi, S. V., Cleland, J. G., Welsh, P., et al. (2022) · EClinicalMedicine

Alcohol Consumption and Health EffectsLiver Disease Diagnosis and Treatment

Cited by 41

The effects of 8 months of metformin on circulating GGT and ALT levels in obese women with polycystic ovarian syndrome: PCOS, NAFLD and metformin therapy

Preiss, D., Sattar, N., Harborne, L., Norman, J., & Fleming, R. (2008) · International Journal of Clinical Practice

Ovarian function and disordersLiver Disease Diagnosis and Treatment

Cited by 39

Cardiovascular and mortality outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a meta-analysis with the FREEDOM cardiovascular outcomes trial

Lee, M. M. Y., Kristensen, S. L., Gerstein, H. C., McMurray, J. J. V., & Sattar, N. (2022) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews

Diabetes Treatment and ManagementHeart Failure Treatment and Management

Cited by 37

Ethnicity and risk of cardiovascular disease (CVD): 4.8 year follow-up of patients with type 2 diabetes living in Scotland

on behalf of Scottish Diabetes Research Network (SDRN) Epidemiology group, Malik, M. O., Govan, L., Petrie, J. R., Ghouri, N., Leese, G., Fischbacher, C., Colhoun, H., Philip, S., Wild, S., et al. (2015) · Diabetologia

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management

Cited by 36

Psychological, social and biological determinants of ill health (pSoBid): Study Protocol of a population-based study

Velupillai, Y. N., Packard, C. J., Batty, G. D., Bezlyak, V., Burns, H., Cavanagh, J., Deans, K., Ford, I., McGinty, A., Millar, K., et al. (2008) · BMC Public Health

Health disparities and outcomesPublic Health and Social Inequalities

Cited by 36

Dose–response relationship between device-measured physical activity and incident type 2 diabetes: findings from the UK Biobank prospective cohort study

Boonpor, J., Parra-Soto, S., Petermann-Rocha, F., Lynskey, N., Cabanas-Sánchez, V., Sattar, N., Gill, J. M. R., Welsh, P., Pell, J. P., Gray, S. R., et al. (2023) · BMC Medicine

Physical Activity and HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 31

An Observational Study of Cardiovascular Outcomes of Tirzepatide vs Glucagon-Like Peptide-1 Receptor Agonists

Dani, S. S., Makwana, B., Khadke, S., Kumar, A., Jhund, P., Nasir, K., Sattar, N., Al-Kindi, S., Fonarow, G., Butler, J., et al. (2025) · JACC: Advances

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 30

Sex differences in intraorgan fat levels and hepatic lipid metabolism: implications for cardiovascular health and remission of type 2 diabetes after dietary weight loss

Jesuthasan, A., Zhyzhneuskaya, S., Peters, C., Barnes, A. C., Hollingsworth, K. G., Sattar, N., Lean, M. E. J., Taylor, R., & Al-Mrabeh, A. H. (2022) · Diabetologia

Diabetes, Cardiovascular Risks, and LipoproteinsLiver Disease Diagnosis and Treatment

Cited by 30

Socio‐economic status and mortality in people with type 1 diabetes in Scotland 2006–2015: a retrospective cohort study

Campbell, R. A. S., Colhoun, H. M., Kennon, B., McCrimmon, R. J., Sattar, N., McKnight, J., Wild, S. H., & Scottish Diabetes Research Network Epidemiology Group (2020) · Diabetic Medicine

Diabetes Management and ResearchHealth disparities and outcomes

Cited by 26

Rising rates and widening socioeconomic disparities in diabetic ketoacidosis in type 1 diabetes in scotland: a nationwide retrospective cohort observational study

O’Reilly, J. E., Jeyam, A., Caparrotta, T. M., Mellor, J., Hohn, A., McKeigue, P. M., McGurnaghan, S. J., Blackbourn, L. A. K., McCrimmon, R., Wild, S. H., et al. (2021) · Diabetes Care

Diabetes Management and ResearchDiabetes Management and Education

Cited by 25

Impact of intentional weight loss in cardiometabolic disease: what we know about timing of benefits on differing outcomes?

Sattar, N., Deanfield, J., & Delles, C. (2024) · Cardiovascular Research

Diabetes, Cardiovascular Risks, and LipoproteinsCardiovascular Disease and Adiposity

Cited by 20

High Circulating Triglycerides Are Most Commonly a Marker of Ectopic Fat Accumulation: Connecting the Clues to Advance Lifestyle Interventions

Sattar, N., McGuire, D. K., & Gill, J. M. R. (2022) · Circulation

Diabetes, Cardiovascular Risks, and LipoproteinsCardiovascular Disease and Adiposity

Cited by 19

Are elevated circulating intercellular adhesion molecule 1 levels more strongly predictive of diabetes than vascular risk? Outcome of a prospective study in the elderly

for the Prospective Study of Pravastatin in the Elderly at Risk Trial Study Group, Sattar, N., Murray, H. M., Welsh, P., Blauw, G. J., Buckley, B. M., de Craen, A. J., Ford, I., Forouhi, N. G., Freeman, D. J., et al. (2009) · Diabetologia

Diabetes, Cardiovascular Risks, and LipoproteinsAdipokines, Inflammation, and Metabolic Diseases

Cited by 19

Physical activity, inactivity and sleep during the Diabetes Remission Clinical Trial (DiRECT)

Cassidy, S., Trenell, M., Stefanetti, R. J., Charman, S. J., Barnes, A. C., Brosnahan, N., McCombie, L., Thom, G., Peters, C., Zhyzhneuskaya, S., et al. (2023) · Diabetic Medicine

Physical Activity and HealthSleep and related disorders

Cited by 19

Improvements in Cardiometabolic Risk Factors by Weight Reduction: A Post Hoc Analysis of Adults With Obesity Randomly Assigned to Tirzepatide

Linetzky, B., Sattar, N., Verma, S., Krumholz, H. M., Xie, C. C., Hoffmann, H. T., Zimner-Rapuch, S., Torcello-Gómez, A., & Stefanski, A. (2025) · Annals of Internal Medicine

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 17

Erythrocytosis in offspring of mothers with Type 1 diabetes—are factors other than insulin critical determinants?

Nelson, S. M., Freeman, D. J., Sattar, N., & Lindsay, R. S. (2009) · Diabetic Medicine

Gestational Diabetes Research and ManagementBirth, Development, and Health

Cited by 16

Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults with Obesity (SURMOUNT-4)

Aronne, L. J., Sattar, N., Horn, D. B., Bays, H. E., Wharton, S., Lin, W.-Y., Ahmad, N. N., Zhang, S., Liao, R., Bunck, M. C., et al. (2024) · Diabetologie und Stoffwechsel

Pharmacology and Obesity TreatmentBariatric Surgery and Outcomes

Cited by 13

Variation in the SLC23A1 gene does not influence cardiometabolic outcomes to the extent expected given its association with l-ascorbic acid

Wade, K. H., Forouhi, N. G., Cook, D. G., Johnson, P., McConnachie, A., Morris, R. W., Rodriguez, S., Ye, Z., Ebrahim, S., Padmanabhan, S., et al. (2015) · The American Journal of Clinical Nutrition

Genetic Associations and EpidemiologyNutrition, Genetics, and Disease

Cited by 12

Brief formula low-energy-diet for relapse management during weight loss maintenance in the Diabetes Remission Clinical Trial (DiRECT)

Brosnahan, N., Leslie, W., McCombie, L., Barnes, A., Thom, G., McConnachie, A., Messow, C. M., Sattar, N., Taylor, R., & Lean, M. E. J. (2021) · Journal of Human Nutrition and Dietetics

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 12